Cold Chain News: Q1 Highlights
Add bookmark
The first quarter of 2016 hosted plenty of activity from the pharma and cold chain industries. This was seen in the form of patent challenges, landmark agreements, extreme market reactions as well as a nationwide medicine ban for hundreds of products. Read on for this quarter’s highlights from Cold Chain IQ & Pharma IQ.Biotech firm sets its eyes on launching the first biologistic drone Flash Biologistic has joined the Drones For Life project with the view to make the idea of isoth...
